Clinical Trial Update: Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating the addition of azacitidine to R-CHOP in patients with diffuse large B-cell lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Deltasone (prednisone)
• Oncovin (vincristine)
• Rituxan (rituximab)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Diffuse Large B Cell Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-10